| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 04/20/2004 | US6723519 Compositions and method for determining the presence of rat PTTG peptide in a sample |
| 04/20/2004 | US6723518 Diagnosing mammary gland pathologies; obtain biopsies, screen for expression of chemokines, presence of chemokine indicates pathology |
| 04/20/2004 | US6723511 Suppression of apoptosis in cell; obtain cells, incubate with blocking agent, monitor apoptosis in cells |
| 04/20/2004 | US6723506 Nucleotide sequences coding polypeptide for use treatment of tumors |
| 04/20/2004 | US6723329 Administering an effective amount of a b2l viral envelope protein of a parapox virus and an antigen to enhance immune response |
| 04/20/2004 | US6723320 Using monoclonal antibodies; polymerase chain reactions |
| 04/20/2004 | US6723317 Binds to amino acid sequence 1,2 or 4; identification of human papillomavirus (hpv) 16 viral structures |
| 04/20/2004 | US6723316 Herpes simplex virus-1 Glycoprotein C mutants for treating unwanted hyperproliferative cell growth |
| 04/20/2004 | CA1341454C Alpha-amidating enzyme compositions and processes for their production and use |
| 04/16/2004 | CA2408207A1 Peptides binding protein phosphatase 2a and polynucleotides coding them |
| 04/15/2004 | WO2004031773A1 Fret protease assays for clostridial toxins |
| 04/15/2004 | WO2004031768A2 Method for screening modulators of mitochondrial functioning |
| 04/15/2004 | WO2004031731A2 Methods for controlling proliferation of cells |
| 04/15/2004 | WO2004031415A2 Methods and compositions for rapid development of screening assays nuclear receptors |
| 04/15/2004 | WO2004031414A2 Method for diagnosing prostate cancer |
| 04/15/2004 | WO2004031412A2 Method for diagnosing pancreatic cancer |
| 04/15/2004 | WO2004031411A2 Genes and polypeptides relating to human pancreatic cancers |
| 04/15/2004 | WO2004031409A2 Method for diagnosing chronic myeloid leukemia |
| 04/15/2004 | WO2004031389A1 Polynucleotides and polypeptides derived from lactobacillus rhamnosus hn001 |
| 04/15/2004 | WO2004031388A1 Factor participating in transcriptional regulation |
| 04/15/2004 | WO2004031384A1 Mouse-origin proteins forming domain or use thereof |
| 04/15/2004 | WO2004031380A1 Method of strengthening foreign epitope presentation by mhc class i by inhibiting tap activity |
| 04/15/2004 | WO2004031367A2 Uses of human zven proteins and polynucleotides |
| 04/15/2004 | WO2004031364A2 Proteins associated with cell growth, differentiation, and death |
| 04/15/2004 | WO2004031360A2 Therapeutic aptamers having binding specificity to gp41 of hiv |
| 04/15/2004 | WO2004031358A2 Genetically engineered p30 antigen, improved antigen cocktail, and uses thereof |
| 04/15/2004 | WO2004031357A2 Targeted tumor therapy by use of recombinant adenovirus vectors that selectively replicate in hypoxic regions of tumors |
| 04/15/2004 | WO2004031356A2 Recombinant intracellular pathogen immunogenic compositions and methods for use |
| 04/15/2004 | WO2004031354A2 Human sarcoma-associated antigens |
| 04/15/2004 | WO2004031352A2 Interferon variants with improved properties |
| 04/15/2004 | WO2004031349A2 Polynucleotides and polypeptides in plants |
| 04/15/2004 | WO2004031347A2 Methods and compositions for soluble cpg15 |
| 04/15/2004 | WO2004031345A2 Cytotoxic t-cell epitopes of hiv-1 virus |
| 04/15/2004 | WO2004031242A2 Protein complexes involved in neurological diseases |
| 04/15/2004 | WO2004031237A1 Genes and polypeptides relating to human myeloid leukemia |
| 04/15/2004 | WO2004031236A2 Therapeutic uspa1-derived peptides |
| 04/15/2004 | WO2004031235A1 Regulation of human calcium-independent alpha-latrotoxin receptor |
| 04/15/2004 | WO2004031234A2 Regulation of human calcium-independent alpha-latrotoxin receptor |
| 04/15/2004 | WO2004031233A2 Novel chemokine-like polypeptides |
| 04/15/2004 | WO2004031232A1 Crystal structure of erbb2 and uses thereof |
| 04/15/2004 | WO2004031231A2 Genes and polypeptides relating to prostate cancers |
| 04/15/2004 | WO2004031230A2 Novel mhc ii associated peptides |
| 04/15/2004 | WO2004031229A2 P53 binding polypeptide |
| 04/15/2004 | WO2004031228A1 Protein made of penicillium olsonii, providing resistance against 2-deoxyglucose |
| 04/15/2004 | WO2004031227A1 Transcriptional activator gene for genes involved in cobalamin biosynthesis |
| 04/15/2004 | WO2004031226A1 Immunogenic library of chimeric peptides mimicking the genetic diversity of the hypervariable region v3 of the protein of the envelope of a virus gp 120 of human immunodeficiency |
| 04/15/2004 | WO2004031225A1 Orthopoxvirus vectors, genes and products thereof |
| 04/15/2004 | WO2004031224A2 Hbv mutations associated with reduced susceptibility to adefovir |
| 04/15/2004 | WO2004031222A2 Dna vaccine encoding at least two nonstructural early proteins of papillomavirus |
| 04/15/2004 | WO2004031213A1 Method for the preparation of growth hormone and antagonist thereof having lower levels of isoform impurities thereof |
| 04/15/2004 | WO2004031212A1 Antigenic peptides |
| 04/15/2004 | WO2004031211A2 Hla binding peptides and their uses |
| 04/15/2004 | WO2004031210A2 Optimized multi-epitope constructs and uses thereof |
| 04/15/2004 | WO2004031208A2 Promoter sequences for corticotropin releasing factor binding protein and use thereof |
| 04/15/2004 | WO2004031207A2 Candida albicans cofilin |
| 04/15/2004 | WO2004031206A2 Products for regulating the degradation of collagen and methods for indentifying same |
| 04/15/2004 | WO2004031105A2 Use of a33 antigens and jam-it |
| 04/15/2004 | WO2004030712A1 Controlled release therapeutic wound dressings |
| 04/15/2004 | WO2004030702A1 Drug for auditory dysfunction |
| 04/15/2004 | WO2004030699A1 Use of molecules which interact with the haptoglobin receptor ligand binding |
| 04/15/2004 | WO2004030698A1 Peptide-based passive immunization therapy for treatment of atherosclerosis |
| 04/15/2004 | WO2004030697A1 Use of protein tyrosine phosphatase inhibitors for prevention and/or treatment of cancer |
| 04/15/2004 | WO2004030694A1 Bacteriophage-mediated immunisation against hepatitis |
| 04/15/2004 | WO2004030686A1 Peptides and recombinant proteins mimicking interferons |
| 04/15/2004 | WO2004030636A2 Human papillomavirus polypeptides and immunogenic compositions |
| 04/15/2004 | WO2004030630A2 Focal calcium channel modulation |
| 04/15/2004 | WO2004030622A2 Method of isolation and self-assembly of small protein particles from blood and other biological materials |
| 04/15/2004 | WO2004030619A2 Protein s protects the nervous system from injury |
| 04/15/2004 | WO2004030616A2 Ii-KEY/ANTIGENIC EPITOPE HYBRID PEPTIDE VACCINES |
| 04/15/2004 | WO2004030615A2 Compositions and methods for the diagnosis and treatment of tumor |
| 04/15/2004 | WO2004030448A1 RELATIONSHIP BETWEEN LIPOPROTEIN (a) AND ATHEROMA SCLEROSIS |
| 04/15/2004 | WO2004022630A3 Water-soluble polymer alkanals |
| 04/15/2004 | WO2004015143A3 Endosymbiotic gammaproteobacterium identified in ecteinascidia turbinata |
| 04/15/2004 | WO2004014948A3 Gpi anchored glycoprotein aca as a novel tumor marker |
| 04/15/2004 | WO2004011488A3 Recombinant vesicular stomatitis virus vaccines for viral hemorrhagic fevers |
| 04/15/2004 | WO2004009774A3 Protein conjugates with a water-soluble biocompatible, biogradable polymer |
| 04/15/2004 | WO2004009636A3 Gnrh modulator |
| 04/15/2004 | WO2004007552A8 Cytokine receptor |
| 04/15/2004 | WO2004004451B1 Methods of screening compounds for grk6 modulating activity |
| 04/15/2004 | WO2004003012A3 Novel variants of the papm polypeptide of bacteria of genus streptomyces |
| 04/15/2004 | WO2004000875A3 Novel kcnq polypeptides, modulators thereof, and their uses in the treatment of mental disorders |
| 04/15/2004 | WO2004000351A1 Packaged virus-like particles for use as adjuvants: method of preparation and use |
| 04/15/2004 | WO2003106488A3 Antagonists of cxr3-binding cxc chemokines |
| 04/15/2004 | WO2003104381A3 Methods for the detection of polymorphisms in human gpr50 |
| 04/15/2004 | WO2003104275A3 Genes and polypeptides relating to human colon cancers |
| 04/15/2004 | WO2003103588A3 Methods of using artemisinin-like compounds to prevent or delay the appearance of cancer |
| 04/15/2004 | WO2003103581A3 Compositions and methods for liver growth and liver protection |
| 04/15/2004 | WO2003099859A3 Novel use of adenoviruses and nucleic acids coding therefor |
| 04/15/2004 | WO2003099845A3 Fas peptide mimetics and uses thereof |
| 04/15/2004 | WO2003094849A3 Ferritin fusion proteins for use in vaccines and other applications |
| 04/15/2004 | WO2003091266A3 Protein stabilisation using chaperone proteins |
| 04/15/2004 | WO2003087289A8 Methods for the selection of compounds useful for the treatment of huntington’s disease |
| 04/15/2004 | WO2003087157A3 Differentially expressed genes involved in angiogenesis, the proteins encoded thereby, and methods of using the same |
| 04/15/2004 | WO2003085134A3 Methods of diagnosing and treating colorectal cancer |
| 04/15/2004 | WO2003076646A3 Identification and tissue distribution of two novel spliced variants of the mouse lats2 gene |
| 04/15/2004 | WO2003072602A3 Protein complexes and methods for their use |
| 04/15/2004 | WO2003070752A3 Mhc-peptide complex binding ligands |
| 04/15/2004 | WO2003065010B1 Identification of epitopes on staphylococcal enterotoxins that inhibit transcytosis |
| 04/15/2004 | WO2003054543A3 Probe for mass spectrometry |
| 04/15/2004 | WO2003052119A3 Transporters and ion channels |